Market Cap for Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's latest reported market cap is $226.31B USD. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
NVO
Currently viewingMarket CapSwitch metric
Latest period
$226.31B
YoY change
-20.8%
5Y CAGR
-7.0%
Peak year (2023)
$464.99B
Latest annual
$179.20B
Market Cap history chart for Novo Nordisk (NVO) from 1985 to 2026
Market Cap history table for Novo Nordisk (NVO) from 1985 to 2026
| Fiscal year | Period ended | Reported | Market Cap | YoY |
|---|---|---|---|---|
| 2026 | $179.20B | -20.8% | ||
| 2025 | $226.31B | -41.1% | ||
| 2024 | $383.91B | -17.4% | ||
| 2023 | $464.99B | +51.2% | ||
| 2022 | $307.53B | +19.2% | ||
| 2021 | $257.95B | +57.8% | ||
| 2020 | $163.43B | +18.7% | ||
| 2019 | $137.68B | +23.2% | ||
| 2018 | $111.72B | -16.0% | ||
| 2017 | $133.02B | +46.3% | ||
| 2016 | $90.91B | -39.3% | ||
| 2015 | $149.75B | +34.5% | ||
| 2014 | $111.31B | +11.8% | ||
| 2013 | $99.56B | +10.6% | ||
| 2012 | $90.03B | +37.0% | ||
| 2011 | $65.74B | -0.3% | ||
| 2010 | $65.93B | +70.7% | ||
| 2009 | $38.61B | +20.6% | ||
| 2008 | $32.00B | -22.4% | ||
| 2007 | $41.26B | +52.8% | ||
| 2006 | $27.00B | +45.8% | ||
| 2005 | $18.52B | +0.6% | ||
| 2004 | $18.40B | +30.5% | ||
| 2003 | $14.10B | +39.3% | ||
| 2002 | $10.12B | -27.4% | ||
| 2001 | $13.94B | +13.5% | ||
| 2000 | $12.28B | +35.7% | ||
| 1999 | $9.06B | -7.4% | ||
| 1998 | $9.78B | -9.9% | ||
| 1997 | $10.85B | +55.4% | ||
| 1996 | $6.99B | +35.7% | ||
| 1995 | $5.15B | +45.0% | ||
| 1994 | $3.55B | -4.6% | ||
| 1993 | $3.72B | +11.6% | ||
| 1992 | $3.33B | +27.9% | ||
| 1991 | $2.61B | +33.4% | ||
| 1990 | $1.95B | -3.3% | ||
| 1989 | $2.02B | +102.3% | ||
| 1988 | $998.89M | +83.8% | ||
| 1987 | $543.36M | -34.8% | ||
| 1986 | $833.64M | +13.0% | ||
| 1985 | $737.66M | — |
Market Cap values are taken from Novo Nordisk's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in DKK as filed.
Analysis
In 2026, Novo Nordisk (NVO) market cap totalled $179.20B – declined 20.8% year-over-year.
Over 2021–2026 (5 years), Novo Nordisk market cap expanded at a -7.0% compound annual rate, with a net decline across the window.
Novo Nordisk market cap peaked at $464.99B in 2023; the latest annual figure is $179.20B in 2026 (61.5% below peak).
$464.99B stands as the all-time-high annual market cap, posted in 2023, against a low of $543.36M during 1987.
Within Healthcare, Novo Nordisk (NVO) ranks 8th among 8 peers we track. The peer median for market cap is $311.16B.
Novo Nordisk Market Cap by Year
Novo Nordisk Market Cap 2026: $179.20B
Novo Nordisk market cap in 2026 was $179.20B, declined 20.8% below 2025.
Novo Nordisk Market Cap 2025: $226.31B
Novo Nordisk market cap in 2025 was $226.31B, plunged 41.1% below 2024.
Novo Nordisk Market Cap 2024: $383.91B
Novo Nordisk market cap in 2024 was $383.91B, declined 17.4% below 2023.
Novo Nordisk Market Cap 2023: $464.99B
Novo Nordisk market cap in 2023 was $464.99B, surged 51.2% from 2022. This figure represents the highest annual value in the available history.
Novo Nordisk Market Cap 2022: $307.53B
Novo Nordisk market cap in 2022 was $307.53B.
See more financial history for Novo Nordisk (NVO).
Sector peers — Market Cap
Companies in the same sector as Novo Nordisk, ranked by their latest market cap.
| Company | Market Cap | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $825.77B | Healthcare |
| Johnson & Johnson (JNJ) | $548.34B | Healthcare |
| AbbVie Inc. (ABBV) | $349.67B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $332.91B | Healthcare |
| AstraZeneca PLC (AZN) | $289.41B | Healthcare |
| Merck & Co., Inc. (MRK) | $272.11B | Healthcare |
| Amgen Inc. (AMGN) | $183.05B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $174.74B | Healthcare |
Frequently asked questions
What is Novo Nordisk's market cap?
- Latest reported market cap for Novo Nordisk (NVO) is $226.31B (period ending December 31, 2025).
How has Novo Nordisk market cap changed year-over-year?
- Novo Nordisk (NVO) market cap changed -20.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Novo Nordisk market cap?
- Novo Nordisk (NVO) market cap compound annual growth rate is -7.0% over the most recent 5 years available.
When did Novo Nordisk market cap hit its highest annual value?
- Novo Nordisk market cap reached its highest annual value of $464.99B in 2023.
What was Novo Nordisk market cap in 2025?
- Novo Nordisk (NVO) market cap in 2025 was $226.31B.
What was Novo Nordisk market cap in 2026?
- Novo Nordisk (NVO) market cap in 2026 was $179.20B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
NVO Overview
Company profile, financial tools, and key metrics
NVO Revenue Counter
Earns 9,800 DKK every second. See per minute, hour, and day.
NVO Earnings Counter
Earns 3,248 DKK per second net profit. See per minute, hour, and day.
NVO What If Invested
What if you had invested $1,000? See historical returns from any date.
NVO How It Makes Money
Discover visual breakdown of 309.06B DKK in revenue — where it comes from and where it goes.
NVO Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
NVO Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
NVO Daily Price Character
Balanced · 47.3% historical win rate (green days). Streaks & record days.
NVO Buybacks
0.10% TTM buyback yield. Shareholder yield & SBC comparison.
NVO Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
NVO Dividend Profile
Yield: 4.62%. Safety: 5/8. See full history.
NVO Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
NVO Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.